Showing results (1-10 of 20) with videos related to
Sort By:
Pageof 2
Microbial Cell Factories|September 18, 2015
Optimization of yeast-based production of medicinal protoberberine alkaloidsStephanie Galanie, Christina D SmolkeNature Chemical Biology|August 25, 2014
A microbial biomanufacturing platform for natural and semisynthetic opioidsKate Thodey, Stephanie Galanie, Christina D SmolkeNatural Product Reports|May 5, 2020
Engineering biosynthetic enzymes for industrial natural product synthesisStephanie Galanie, David Entwistle, James LalondeCurrent Opinion in Biotechnology|March 27, 2013
Molecular tools for chemical biotechnologyStephanie Galanie, Michael S Siddiqui, Christina D SmolkeScience (New York, N.Y.)|August 15, 2015
Complete biosynthesis of opioids in yeastStephanie Galanie, Kate Thodey, Isis J Trenchard, et al.Structure (London, England : 1993)|November 5, 2020
Malleability of the SARS-CoV-2 3CL Mpro Active-Site Cavity Facilitates Binding of Clinical AntiviralsDaniel W Kneller, Stephanie Galanie, Gwyndalyn Phillips, et al.Journal of Medicinal Chemistry|October 27, 2021
Structural, Electronic, and Electrostatic Determinants for Inhibitor Binding to Subsites S1 and S2 in SARS-CoV-2 Main ProteaseDaniel W Kneller, Hui Li, Stephanie Galanie, et al.Analytical Chemistry|January 2, 2024
Accelerating Pharmaceutical Process Development with an Acoustic Droplet Ejection-Multiple Reaction Monitoring-Mass Spectrometry WorkflowHang Hu, Andrew N Singh, Dan Lehnherr, et al.Frontiers in Plant Science|August 7, 2023
Validation of a metabolite-GWAS network for Populus trichocarpa family 1 UDP-glycosyltransferasesPatricia M B Saint-Vincent, Anna Furches, Stephanie Galanie, et al.Biorxiv : the Preprint Server for Biology|November 24, 2021
Structural and functional characterization of NEMO cleavage by SARS-CoV-2 3CLproMikhail Ali Hameedi, Erica T Prates, Michael R Garvin, et al.Pageof 2